Posner Brian S 4
4 · Dyne Therapeutics, Inc. · Filed Oct 2, 2025
Insider Transaction Report
Form 4
Posner Brian S
Director
Transactions
- Award
Stock option (right to buy)
2025-10-01+70,000→ 70,000 totalExercise: $12.50Exp: 2035-09-30→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The option was granted on October 1, 2025. The shares underlying the option are scheduled to vest over three years in equal monthly installments through October 1, 2028.